7. CONCLUSION
Our meta-analysis suggests that statin pre-treatment before cardiac surgery is not associated with a significant reduction of POAF occurrence. Severe heterogeneity between the considered study does exist. Until the results of the START-CABG trial are available and considering the potential acute kidney injury, we discourage statin pre-treatment in preventing POAF.